EMA – Public consultation: Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease
The current guideline requires revision to incorporate recent developments in the definition of AD. These changes have important implications for the design and conduct of clinical trials across all stages of sporadic AD.
The draft concept paper can be found on the dedicated page on the EMA Website.
The deadline for comments is 28 February 2026. Templates and other open consultations can be found on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (20 septembre 2025). EMA – Public consultation: Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/14pwx





